Key takeaways
- NAD+ is a coenzyme essential to cellular energy production and DNA repair, and its levels are widely reported to decline with age.
- Most human research focuses on precursors like NMN and NR rather than NAD+ itself; controlled trials show these can raise blood NAD+ levels and appear generally well tolerated.
- Clear, consistent proof of clinical or anti-aging benefit in humans is still lacking — the strongest reviews describe many open questions.
- NAD+ supplementation is best understood as early-stage research, not an established treatment.
- Any approach should involve qualified physician oversight and honest expectations.
What is NAD+?
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell. It plays a central role in metabolism, acting as a shuttle that helps cells convert nutrients into usable energy. Beyond energy production, NAD+ is a substrate for enzymes involved in DNA repair and cellular signaling, which is part of why it has drawn so much interest in aging research.
A frequently cited observation is that NAD+ levels appear to decline with age across many tissues. This has led to the hypothesis that restoring NAD+ might support cellular health later in life. It is important to frame this clearly: the decline is an observation and a hypothesis-generator, not by itself proof that raising NAD+ reverses aging or treats any condition.
How NAD+ is thought to work
Because NAD+ itself is not absorbed well when taken orally, most research and supplementation strategies focus on precursors — molecules the body can convert into NAD+. The most studied are nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR). The idea is that supplying these building blocks helps cells maintain or restore NAD+ levels.
Mechanistically, NAD+ supports mitochondrial function and serves as fuel for enzyme families such as sirtuins and PARPs, which are involved in stress responses and DNA repair. An authoritative 2023 review in Endocrine Reviews lays out this biology in detail while emphasizing that many fundamental questions remain unresolved — including how tightly tissue NAD+ levels are regulated and whether raising them produces the downstream effects the mechanism would predict.
What the research shows
The honest summary is that human evidence is still developing. A 2023 multicentre randomized controlled trial published in Geroscience examined NMN supplementation in healthy middle-aged adults. Controlled trials of this kind are the most reliable type of human data available for NAD+ precursors, and they provide a measured picture: precursors can raise blood NAD+ levels and appear generally well tolerated over the studied periods.
A 2025 review in Nature Metabolism on NAD+ precursor supplementation in human aging offers a balanced appraisal of the broader literature. It notes that while precursors reliably increase NAD+ markers, the trials do not yet demonstrate clear, consistent clinical benefits, and study designs, durations, and endpoints vary widely. In short, the foundational biology is compelling and human safety signals so far are reassuring, but proof of meaningful anti-aging or disease-modifying benefit in people is not established. This is early research, not settled science.
What it is being explored for
Researchers are studying NAD+ precursors in the context of healthy aging, metabolic health, mitochondrial function, and recovery. People drawn to NAD+ are often interested in supporting cellular energy and general vitality as they age, and the existing trials have generally focused on healthy adults rather than treating specific diseases.
Given the current state of evidence, NAD+ is most accurately positioned as something being explored rather than something proven to deliver a defined outcome. Anyone considering it should hold realistic expectations and recognize that individual responses, appropriate candidacy, and the relevance to one's own health are matters for a qualified clinician — not something to infer from headlines.
How Strong Craft Regen approaches NAD+
Strong Craft Regen is a coordination and education service. We do not provide medical advice or treatment ourselves; we help people understand options and coordinate care delivered by licensed physicians at Innovita Clinic in Vilnius, Lithuania. With NAD+, our approach is to reflect the evidence honestly — including its limits — so decisions are made with clear eyes.
That means any interest in NAD+ is reviewed within a proper clinical relationship, where a physician can consider your history, goals, and whether such an approach is appropriate for you. If you would like to learn more or discuss whether this fits your situation, you are welcome to book a call. Our role is to organize and inform, while medical decisions stay with the treating physicians.
The evidence
Selected peer-reviewed references, each verified against PubMed. Explore the full, filterable research library on our Science page.
This article is for educational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. NAD+ is discussed in the context of the published research; inclusion of a study does not imply a guaranteed outcome. Many of these compounds are investigational and not approved for the uses described in all jurisdictions. Any treatment decision should be made with a qualified physician. Individual results vary.